121 related articles for article (PubMed ID: 21570337)
1. CCR2-64I gene polymorphism increase susceptibility to oral cancer.
Chen MK; Yeh KT; Chiou HL; Lin CW; Chung TT; Yang SF
Oral Oncol; 2011 Jul; 47(7):577-82. PubMed ID: 21570337
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
[TBL] [Abstract][Full Text] [Related]
3. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
Bektas-Kayhan K; Unur M; Boy-Metin Z; Cakmakoglu B
Oral Dis; 2012 Jan; 18(1):55-9. PubMed ID: 21883707
[TBL] [Abstract][Full Text] [Related]
4. The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer.
Chen MK; Chiou HL; Su SC; Chung TT; Tseng HC; Tsai HT; Yang SF
Oral Oncol; 2009 Dec; 45(12):e222-6. PubMed ID: 19717330
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
[TBL] [Abstract][Full Text] [Related]
6. CCR2-64I is a risk factor for development of bladder cancer.
Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
[TBL] [Abstract][Full Text] [Related]
7. CCR2-64I polymorphism is associated with Non-Small Cell Lung Cancer in Tunisian patients.
Rafrafi A; Kaabachi S; Kaabachi W; Chahed B; Amor AB; Mbarik M; Charrad R; Salah MO; Hamzaoui K; Sassi FH
Hum Immunol; 2015 May; 76(5):348-54. PubMed ID: 25797207
[TBL] [Abstract][Full Text] [Related]
8. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis.
Cho YA; Kim J
Cytokine; 2013 Oct; 64(1):213-20. PubMed ID: 23876399
[TBL] [Abstract][Full Text] [Related]
9. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer.
Weng CJ; Chen MK; Lin CW; Chung TT; Yang SF
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S319-27. PubMed ID: 21512861
[TBL] [Abstract][Full Text] [Related]
11. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.
Kang SW; Park SJ; Kim YW; Kim YH; Sohn HS; Yoon YC; Joo H; Jeong KH; Lee SH; Lee TW; Ihm CG
Int J Immunogenet; 2008 Feb; 35(1):25-31. PubMed ID: 18186797
[TBL] [Abstract][Full Text] [Related]
12. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
13. Relationship between CCR2-V64I polymorphism and cancer risk: a meta-analysis.
Huang Y; Chen H; Wang J; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Jul; 524(1):54-8. PubMed ID: 23612252
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma.
Brocic M; Supic G; Zeljic K; Jovic N; Kozomara R; Zagorac S; Zlatkovic M; Magic Z
Otolaryngol Head Neck Surg; 2011 Oct; 145(4):586-93. PubMed ID: 21705789
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
[TBL] [Abstract][Full Text] [Related]
16. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease.
Bai J; Song H; Cai C; Zhang M; Xu S; Tan J
DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574
[TBL] [Abstract][Full Text] [Related]
17. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population.
Bharti V; Mohanti BK; Das SN
Hum Immunol; 2013 Mar; 74(3):348-52. PubMed ID: 23246583
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma.
Hsiao PC; Chen MK; Su SC; Ueng KC; Chen YC; Hsieh YH; Liu YF; Tsai HT; Yang SF
J Surg Oncol; 2010 Aug; 102(2):163-9. PubMed ID: 20648588
[TBL] [Abstract][Full Text] [Related]
19. Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer.
Teng YH; Liu TH; Tseng HC; Chung TT; Yeh CM; Li YC; Ou YH; Lin LY; Tsai HT; Yang SF
Head Neck; 2009 Oct; 31(10):1282-8. PubMed ID: 19373784
[TBL] [Abstract][Full Text] [Related]
20. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
